Tuesday, July 25, 2017
 
 
Company News: Page (1) of 1 - 05/16/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Glucose Meter Connecting Diabetes Patients To Trusted Care Team Approved In U.S. And Europe
iGlucose® Monitoring System Provides Texting, eMail, and Secure Real-Time Cloud Communication of Diabetes Results and Data Between Person with Diabetes, Loved Ones and Healthcare Team
(May 16, 2017)

NEW YORK, May 16, 2017 /PRNewswire/ -- Smart Meter, LLC announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark in Europe to market the iGlucose® Blood Glucose Monitoring System. Aimed at improving health outcomes for people with diabetes, the iGlucose® System is the first subscription-free glucose meter and diabetes health management system to offer automatic transmission of diabetes information to a cloud-based personalized web portal, while also facilitating simple, real-time mobile communication between the person with diabetes and those individuals in his or her designated Circle of Care.

The iGlucose® Blood Glucose Monitoring System offers automatic transmission of diabetes information to a cloud-based personalized web portal, while facilitating simple, real-time mobile communication between the person with diabetes and the family members, friends and healthcare professionals who are part of his or her designated Circle of Care.

The iGlucose System uses digital mobile phone technology known as Global System for Mobile communication (GSM) to facilitate two-way communication between an individual's iGlucose® Meter and the iGlucose® Web Portal. Mobile health solutions, also known as mHealth, have been recognized to lower both cost and HbA1c, the key measure of an individual's blood glucose average. For the iGlucose System, GSM connectivity provides several benefits, including the following:


  • iGlucose Blood Glucose Meter communicates automatically with the cloud
  • iGlucose Web Portal empowers a user's Circle of Care (healthcare providers, friends and family) to support the person's diabetes management efforts
  • iGlucose System provides actionable data to healthcare professionals and payers to enable digital triage improving population health management

"While more than 400 million people have diabetes globally, managing it can be a lonely and frustrating journey for them if their healthcare professionals and loved ones aren't adequately involved in day-to-day care. Being digitally connected with their Circle of Care has proven to turn the tide for many people with diabetes," said Cliff McIntosh, CEO for Smart Meter, LLC. "The web-connected glucose meters available today have shown limited results because they're so complicated to use. We're excited about our regulatory approvals because the iGlucose System's ease of use makes it possible for family, friends, and healthcare professionals to be truly engaged and support the person with diabetes in their daily diabetes management."

Different from other web-connected glucose meters, the iGlucose Meter comes ready, out-of-the-box, for communicating via the cloud. After a simple registration on the web portal using the meter's serial number and the user's diabetes information, the meter and web portals are set for continuous two-way interaction, with no additional steps required.

Communication to and from the web portal happens automatically with no cables to connect, no Bluetooth to synch, no wi-fi requirement, no uploads to remember, and no telecommunication specs to program. The person with diabetes only needs to check his or her blood glucose.  The meter and web portal handle the rest, communicating automatically in real time by way of a global Internet of Things (IoT) network. The iGlucose System's two-way communication is possible in more than 200 countries without any additional cost to patients and without the need for country-by-country IT integration or a specific brand of phone or mobile carrier.

While tracking a person's glucose results and diabetes information is one important function of the iGlucose Web Portal, the system also proactively initiates and manages multiple two-way communications between itself, the person with diabetes, and their desired Circle of Care designated during registration. The portal integrates the person's diabetes data in easy-to-read charts, graphs and an e-diary to display at-a-glance trends. It also sends personalized diabetes tips, coaching suggestions, and reminders via system-generated texts and emails from the iGlucose® Coach to the user, while also providing real-time alerts to their Circle of Care, informing them of glucose readings and other important information. This makes it possible, for example, for a pharmacy to remind the user to refill test strips, or for a nurse or loved one to text encouraging notes or reminders that can help keep a person's diabetes management efforts on track.

Finally, with its web-based software powered by automated real-time data collection, the iGlucose System's cloud-based portal makes actionable health data available to healthcare professionals and payers. For instance, the software can identify "hot spots" in a physician's diabetes population to enable digital triage. This now frees the physician to focus on the right patients at the right times based on what's revealed in their diabetes data, such as low or out-of-control glucose levels. For payers, the data collection capabilities of the web portal provide a cost-effective solution for accessing validated data on test strip usage, replenishment, and compliance, which helps improve health outcomes.

The iGlucose Blood Glucose Monitoring System uses just 0.75 µl of blood, features a five-second test time plus flagging of before- and after-meal results, and meets ISO 2013 standards in providing accurate blood glucose readings. In addition, the price of test strips and the meter will be equal to or less than the copays of leading brands.

Initial markets where the iGlucose System will be sold include the United States and the United Kingdom, with product expected to be commercially available in both markets sometime in 2017.

About Smart Meter, LLC
Smart Meter, LLC is a medical device company and mHealth solutions provider focused on bringing reliable and efficient device connectivity to their customers around the world.  Its iGlucose® Blood Glucose Monitor is an affordable, state-of-the-art blood glucose meter with built-in GSM connectivity, allowing people with diabetes to create a customizable network of care via a personal web portal. The iGlucose® Platform provides a new level of connectivity for the person with diabetes, the health care professional, and the payer, resulting in better diabetes management while saving time and money. To learn more, please visit www.SmartMeterCorporation.com or www.iGlucose.com.

MEDIA CONTACT:
Jeff Christensen
SignalWest Public Relations, LLC
+1-831-566-0275
Jeff@SignalWestPR.com

INVESTOR CONTACT:
Wycliffe (Cliff) X. McIntosh
Smart Meter, LLC
+1-813-641-8822
Cliff.McIntosh@iGlucose.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/glucose-meter-connecting-diabetes-patients-to-trusted-care-team-approved-in-us-and-europe-300458165.html

SOURCE Smart Meter, LLC

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA, Medicine, healthcare, Surgery, Physician, Nurse, Science, Communications Technology, Internet Technology, Medical, Internet, Email, Family, Other, Medical Professionals,
Related Sites: AEC Newsroom ,   Audio Video Producer ,   Corporate Media News ,   itbusinessnet.com ,   HTN - Health Technology Net
Related Newsletter: Digital Media Net ,   DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Global Neuropsychiatric Disorders And Treatment Market Is Expected To Grow At A CAGR Of 6.2% During Forecast 2023
  • ChiRhoStim® (Human Secretin for Injection) FDA approved labeling update and 5-year shelf life approval
  • Wound Closure and Advanced Wound Care Global Market Forecast To 2023
  • Longeveron to Sponsor Industry Symposium on Regenerative Medicine at 2017 IAGG World Congress
  • Regenerative Medicine Market Size Worth $5.59 Billion by 2025: Grand View Research, Inc.

    Cancer
  • After 20 Years of Scrutiny Researchers Confirm Surgery for Early Prostate Cancer May Not Save Lives
  • Varian to Showcase Latest Radiotherapy and Radiosurgery Technologies and Software at AAPM 2017
  • American Brain Tumor Association's Annual Patient and Family Conference to Address Physical and Cognitive Symptoms and Side Effects
  • St. Jude Children's Research Hospital®, ALSAC Announce Chairs of Boards of Directors and Governors
  • Montgomery Gentry Headlines 9th Annual Country on the Beach in Key West, Florida Benefitting the T.J. Martell Foundation
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines